NCT05449340

Brief Summary

This project is a follow-on study of the BEAUTIFY-2 study (NCT04957186). The "BEAUTIFY" (BrEast cAncer qUaliTy of lIfe aFter surgerY) program was built by a committee of experts on the basis of reflections carried out within 2 focus groups. An application was developed to track patient reported outcome measures. The study investigators now wish to evaluate the feasibility and impact on pain and quality of life of the "BEAUTIFY" care pathway on a larger cohort. The study hypothesis is that multidisciplinary care organization will improve the management and the quality of life post-breast cancer surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 8, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

July 25, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 16, 2024

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

1.6 years

First QC Date

June 27, 2022

Last Update Submit

February 29, 2024

Conditions

Keywords

mastectomyquality of life

Outcome Measures

Primary Outcomes (2)

  • Patient compliance with the program

    Yes/No: study will be considered feasible if at least 80% of patients complete the program

    End of study (12 months)

  • Patient satisfaction with the intervention

    Yes/No: study will be considered feasible if at least 80% of patients are satisfied.

    End of study (12 months)

Secondary Outcomes (12)

  • Compliance with completing the BEAUTIFY application

    End of study (12 months)

  • Patient quality of life following surgery

    Baseline

  • Patient quality of life following surgery

    1 month

  • Patient quality of life following surgery

    3 months

  • Patient quality of life following surgery

    6 months

  • +7 more secondary outcomes

Study Arms (1)

BEAUTIFY application

EXPERIMENTAL
Device: BEAUTIFY application

Interventions

Interview with the coordinating nurse in the postoperative period to install the BEAUTIFY application on the patient's smartphone and to train her to record any Patients will monitor their symptoms weekly. In case of toxicity grade \> 2, the nurse will contact the patient for further information.

BEAUTIFY application

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer patient scheduled for surgery
  • Patient able to use a connected electronic object and having a tablet or a smartphone with internet access at home.
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

You may not qualify if:

  • The subject unable to express consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes

Nîmes, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Frédéric Fiteni

    CHU de Nimes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

July 8, 2022

Study Start

July 25, 2022

Primary Completion

February 16, 2024

Study Completion

February 16, 2024

Last Updated

March 1, 2024

Record last verified: 2024-02

Locations